González-Tablas, M.; Arandia, D.; Jara-Acevedo, M.; Otero, Á.; Vital, A.-L.; Prieto, C.; González-Garcia, N.; Nieto-Librero, A.B.; Tao, H.; Pascual, D.;
et al. Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival. Cancers 2020, 12, 231.
https://doi.org/10.3390/cancers12010231
AMA Style
González-Tablas M, Arandia D, Jara-Acevedo M, Otero Á, Vital A-L, Prieto C, González-Garcia N, Nieto-Librero AB, Tao H, Pascual D,
et al. Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival. Cancers. 2020; 12(1):231.
https://doi.org/10.3390/cancers12010231
Chicago/Turabian Style
González-Tablas, María, Daniel Arandia, María Jara-Acevedo, Álvaro Otero, Ana-Luisa Vital, Carlos Prieto, Nerea González-Garcia, Ana Belén Nieto-Librero, Herminio Tao, Daniel Pascual,
and et al. 2020. "Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival" Cancers 12, no. 1: 231.
https://doi.org/10.3390/cancers12010231
APA Style
González-Tablas, M., Arandia, D., Jara-Acevedo, M., Otero, Á., Vital, A.-L., Prieto, C., González-Garcia, N., Nieto-Librero, A. B., Tao, H., Pascual, D., Ruiz, L., Sousa, P., Galindo-Villardón, P., Orfao, A., & Tabernero, M. D.
(2020). Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival. Cancers, 12(1), 231.
https://doi.org/10.3390/cancers12010231